TABLE 1.

Some examples of NDs used in drugs development and drugs delivery applications.

Nanodiscs type	Inserted	Applications	References
MSP nanodiscs	Hydrophobic drugs&Cabazitaxel	Cancer chemotherapy	Pandey et al. (2021)
MSP nanodiscs (Lipids modified)	—	Antibody-conjugated NDs for targeted cancer imaging	Wong et al. (2020)
MSP nanodiscs	Influenza virus M2 protein	Antibody Discovery	Yu et al. (2023)
apoA I-stabilized Nanodiscs (like MSP nanodiscs)	Amphotericin B	Anti-fungal drug delivery	Cho et al. (2017)
ApoJ-stabilized Nanodiscs (like MSP nanodiscs)	—	Alzheimer’s disease treatment	Fernandez-de-Retana et al. (2017)
Peptide nanodiscs	Adpgk & CM9 peptides	Cancer vaccine	Najafabadi et al. (2021)
Peptide nanodiscs	DTX/CpG	ICD inducer	Kadiyala et al. (2019)
Peptide nanodiscs (KT peptide modified)	T0901317	LXR agonist for diabetic nephropathy	He et al. (2022)
Peptide nanodiscs	ML355	Antiplatelet drug	He et al. (2020)
SMA nanodiscs	Bacterial Outer Membrane	Antibacterial Vaccination	Noh et al. (2022)

CBZ, cabazitaxel; DTX, docetaxel; KT, kidney targeting; ICD, immunogenic cell death.